RADX (Radiopharm Theranostics Limited) Stock Market Reviews

crown

search

Read and share opinions on RADX (Radiopharm Theranostics Limited) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock

RADX

Radiopharm Theranostics Limited

clarify Biotechnology

bookmark Healthcare

public Australia

Sell Neutral Buy

Latest News

Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204
Nov 12, 2025
RADX: Program and Financial Updates
Nov 3, 2025
Radiopharm Theranostics Expects to Raise $22.7 Million Via Private Placement, Shares Down Pre-Bell
Oct 20, 2025
Radiopharm receives DSMC recommendation to advance Phase 1 ‘HEAT’ trial
Oct 2, 2025
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial
Oct 1, 2025
RADX: RAD101: Imaging Recurring Brain Metastases
Sep 29, 2025
RADX: Prostate Cancer KOL Summary
Sep 8, 2025
Radiopharm Theranostics Limited (RADX) Receives IND Approval From FDA To Initiate Phase I Therapeutic Clinical Study To Target B7H3 With Betabart (RV-01)
Aug 17, 2025
RADX: July 2025 Update
Aug 4, 2025
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
Jul 28, 2025
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
Jun 24, 2025
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake
Jun 2, 2025

Reviews